- |||||||||| prednisone / Generic mfg.
Trial completion, Trial initiation date, Trial primary completion date: Vapreda: Vaginal Prednisone Administration for Prevention of Adrenal Crisis (clinicaltrials.gov) - May 30, 2017 P2, N=12, Completed, Recruiting --> Completed | N=50 --> 89 | Trial primary completion date: Sep 2015 --> Jun 2016 Not yet recruiting --> Completed | Initiation date: Apr 2016 --> Jan 2017 | Trial primary completion date: Oct 2016 --> Apr 2017
- |||||||||| Trial completion, Trial initiation date: Adrenal Function After Living Kidney Donation (clinicaltrials.gov) - Dec 29, 2016
P=N/A, N=30, Completed, Active, not recruiting --> Completed | N=10 --> 2 Recruiting --> Completed | Initiation date: Dec 2005 --> Jan 2007
- |||||||||| Solu-Cortef (hydrocortisone sodium succinate injection) / Pfizer
Enrollment closed, Trial primary completion date: Continuous Subcutaneous Hydrocortisone Infusion In Addison's Disease and Type 1 Diabetes (clinicaltrials.gov) - Dec 4, 2015 P2, N=10, Active, not recruiting, Recruiting --> Completed | Initiation date: Dec 2005 --> Jan 2007 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Dec 2016
- |||||||||| Solu-Cortef (hydrocortisone sodium succinate injection) / Pfizer
Trial completion: Glucocorticoid Treatment in Addison's Disease (clinicaltrials.gov) - Mar 18, 2013 P2/3, N=33, Completed, N=500 --> 0 Active, not recruiting --> Completed
- |||||||||| Synacthen Depot (cosyntropin) / Novartis, Mallinckrodt, Alliance
Trial completion: RoSA: Revival of Stem Cells in Addison's Study (clinicaltrials.gov) - Feb 4, 2013 P4, N=13, Completed, Active, not recruiting --> Completed Recruiting --> Completed
|